Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer's Disease

被引:66
作者
Cole, Greg M. [1 ,2 ]
Frautschy, Sally A. [1 ,2 ]
机构
[1] Greater Los Angeles Healthcare Syst, Geriatr Res & Educ Ctr, Vet Adm, North Hills, CA 91343 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA
关键词
Alzheimer's disease; cyclooxygenases; non-steroidal anti-inflammatory drugs; docosahexaenoic acid; curcumin; AMYLOID PRECURSOR PROTEIN; MILD COGNITIVE IMPAIRMENT; TRANSGENIC MOUSE MODEL; CEREBROSPINAL-FLUID; ANIMAL-MODEL; DOUBLE-BLIND; A-BETA; CONTROLLED-TRIAL; DOWNS-SYNDROME; TAU PATHOLOGY;
D O I
10.2174/187152710791011991
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is accompanied by an activation of the innate immune system, and many epidemiological studies have shown reduced risk for dementia or AD associated with chronic consumption of non-steroidal anti-inflammatory drugs (NSAIDS). These observations led to animal model studies to test the hypothesis that NSAIDs can be disease-modifying for some aspects of AD pathogenesis. NSAIDS cannot only suppress inflammatory targets, which could contribute to neuroprotection, they also slow amyloid deposition by mechanisms that remain unclear. Several large clinical trials with NSAID therapies with AD subjects have failed, and cyclooxygenase-2 does not appear to be a useful target for disease modifying therapy. However, there may be apolipoprotein E E4 pharmacogenomic effects and a real but delayed positive signal in a large primary prevention trial with naproxen. This encourages researchers to re-address possible mechanisms for a stage-dependent NSAID efficacy, the subject of this review.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 100 条
[51]  
Laino C, 2009, NEUROL TODAY, V9, P21
[52]   Lack of specific amyloid-β(1-42) suppression by nonsteroidal anti-inflammatory drugs in young, plaque-free Tg2576 mice and in guinea pig neuronal cultures [J].
Lanz, TA ;
Fici, GJ ;
Merchant, KM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (01) :399-406
[53]   Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology [J].
Liang, Winnie S. ;
Dunckley, Travis ;
Beach, Thomas G. ;
Grover, Andrew ;
Mastroeni, Diego ;
Ramsey, Keri ;
Caselli, Richard J. ;
Kukull, Walter A. ;
McKeel, Daniel ;
Morris, John C. ;
Hulette, Christine M. ;
Schmechel, Donald ;
Reiman, Eric M. ;
Rogers, Joseph ;
Stephan, Dietrich A. .
NEUROBIOLOGY OF AGING, 2010, 31 (04) :549-566
[54]   Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype [J].
Licastro, F ;
Mallory, M ;
Lawrence, AH ;
Masliah, E .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) :105-110
[55]   A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model [J].
Lim, GP ;
Calon, F ;
Morihara, T ;
Yang, FS ;
Teter, B ;
Ubeda, O ;
Salem, N ;
Frautschy, SA ;
Cole, GM .
JOURNAL OF NEUROSCIENCE, 2005, 25 (12) :3032-3040
[56]   Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice [J].
Lim, GP ;
Yang, F ;
Chu, T ;
Gahtan, E ;
Ubeda, O ;
Beech, W ;
Overmier, JB ;
Hsiao-Ashe, K ;
Frautschy, SA ;
Cole, GM .
NEUROBIOLOGY OF AGING, 2001, 22 (06) :983-991
[57]   Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease [J].
Lim, GP ;
Yang, F ;
Chu, T ;
Chen, P ;
Beech, W ;
Teter, B ;
Tran, T ;
Ubeda, O ;
Ashe, KH ;
Frautschy, SA ;
Cole, GM .
JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5709-5714
[58]   The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse [J].
Lim, GP ;
Chu, T ;
Yang, FS ;
Beech, W ;
Frautschy, SA ;
Cole, GM .
JOURNAL OF NEUROSCIENCE, 2001, 21 (21) :8370-8377
[59]  
Lukiw WJ, 1997, J NEUROSCI RES, V50, P937, DOI 10.1002/(SICI)1097-4547(19971215)50:6<937::AID-JNR4>3.0.CO
[60]  
2-E